A well-developed serum can become a cornerstone product that builds brand credibility and repeat purchases, while a poorly developed one may struggle with stability, consumer dissatisfaction, or regulatory issues
While safety within the phase 3 program is sufficient for marketing authorization (although the risk of cardiovascular events should not exceed a hazard ratio of 1.8 according to a guidance document that was released by the FDA at that time), it is the post-marketing phase in which rare adverse events and any other potential safety risks are identified or resolved
[DOI] [PubMed] [Google Scholar] 32.Ablin J., Fitzcharles M.-A., Buskila D., Shir Y., Sommer C., Huser W
Al realizar la comparacin con los indicadores antropomtricos pre y post de la aplicacin con L-carnitina IV (T de Student), se encontr una diferencia significativa para peso seco e ndice de masa corporal (p=0.04) (Cuadro 2)